An advisory panel for the Centers for Disease Control and Prevention voted Wednesday to certify the use of Pfizer’s Covid-19 vaccine and BioNTech for 12 to 15 year olds to find a way for pediatricians to begin providing images across the United States by: soon It’s thursday
Recommendations by the Advisory Committee on Immunization Practices, 14-0 Reuse Approved, Two days after the Food and Drug Administration approved Pfizer and Bioenter requests. To allow fire to be fired by teenagers in an emergency. The certification is currently awaiting final approval by CDC Director Dr. Rochelle Valensky, which is expected to take place shortly.
During Wednesday̵7;s meeting, CDC officials said there were no serious adverse events associated with the Pfizer-BioNTech Among the more than 2,000 children in the company’s clinical trials, 91% of vaccine recipients experienced some type of side effects.
The most commonly reported side effects include pain at the injection site, joint and muscle weakness, headache, chills, and fever. Pfizer Scientist John Perez told the committee. With the exception of the pain at the injection site, many teens reported more side effects after the second dose than the first. Side effects usually resolve within one to two days, he said.
The CDC board endorsement comes ahead of the summer camp season and July 4, the day the Biden’s administration hopes to be a turning point in the nation’s fight against the virus. More than 3.3 million people die from COVID-19, with nearly 600,000 in the United States, according to data compiled by Johns Hopkins University.
After Wednesday’s vote, several members expressed excitement that their family members could have been vaccinated.Others noted that access to the images would help children return to normal after needing. Suffers a year of psychological and social challenges due to the epidemic
“My husband and I have been vaccinated. I am 16, have been vaccinated, and now I am 12 and 15 will line up,” said ACIP member Keipp Talbot.
The advice of the committee will “Help us close a difficult chapter for many children and families,” said Andy Slavitt, senior White House official on the country’s plans to deal with COVID-19, via Twitter.
Vaccination of children is seen as important in ending the epidemic. The country is unlikely to have herd immunity – when people in the community have enough antibodies to a specific disease – until the children are vaccinated, health officials and experts say.
Children make up about 20% of the total US population of 331 million, according to government data. Experts say between 70% and 85% of the population of the United States must be vaccinated against COVID in order to keep herd immunity, and some adults may refuse to receive such shots. Although many experts say herd immunity is becoming increasingly improbable with the spread of various species.
As of Tuesday, more than 150 million Americans aged 18 and over received at least one dose, according to data compiled by the CDC.The CDC showed that about 115 million American adults were fully vaccinated, about 13% of adults said they. He’s definitely not going to get the vaccine, while 21% say they’ll “wait and see” or get it only when needed, according to the Kaiser Family Foundation.
CDC officials told the committee that research showed vaccination hesitancy among parents, with only 46% to 60% saying they wanted their children to be vaccinated. Reasons for not getting a picture include concerns about safety, time it takes to develop the vaccine and not having enough information, officials said.
On Monday, Dr. FDA Director Janet Woodcock reassured the parent that the US agency “Perform a rigorous and thorough review of all available information” before applying it to teenagers.
CDC official Dr Megan Wallace said Wednesday’s serious adverse events were 0.4% more common in the vaccine group than those given the placebo, compared with 0.2%, but none of these were caused by the shots. say
Perez said one of the adverse reactions associated with the vaccine is lymph node swelling. In clinical trials, nine patients were involved in the vaccine group, seven of which were involved in vaccination. Two cases were in the placebo group, he said. There were no cases of anaphylaxis according to the slides presented at the meeting. There were also no cases of Bell’s Palsy, a rare problem in some adult vaccine recipients or with blood clots, Perez said.
The vaccine was found to be 100% effective in clinical trials of children 12 to 15 years of age. No deaths were reported. More serious side effects were more common in the vaccine group, with approximately 11% reporting pain at the injection site that prevented daily activities, severe fever, headache or muscle pain.